<DOC>
	<DOCNO>NCT02316561</DOCNO>
	<brief_summary>The purpose study investigate feasibility preoperative , single dose , ablative partial breast radiation treatment patient early-stage breast cancer .</brief_summary>
	<brief_title>Single Dose Ablative Radiation Treatment Early-Stage Breast Cancer</brief_title>
	<detailed_description>A total twenty-five patient treat single dose preoperative ablative radiation treatment . After vigilant follow-up MRI , breast conserving surgery perform 6 month ablative radiation treatment . The total follow-up time 10 year . This study aim present ablative radiotherapy treatment approach could resolve extent disadvantage current breast conserving treatment elderly low-risk breast cancer patient currently treat accord guideline due co-morbidity .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>WHO performance scale â‰¤2 . Females least 50 year age unifocal cT1N0 breast cancer females least 70 year age unifocal cT12 ( maximum 3 cm ) N0 breast cancer : Tumor size assess MRI On tumor biopsy : Nonlobular invasive histological type carcinoma . LCIS accept . ER positive tumor receptor . Tumor negative sentinel node . Adequate communication understand skill Dutch language . Legal incapacity Indication chemotherapy immunotherapy ( i.e . patient indication endocrine therapy eligible ) BRCA gene mutation . Previous history breast cancer Other type malignancy within 5 year breast cancer diagnosis . For adequately treat carcinoma situ cervix basal cell carcinoma skin specific time span breast cancer diagnosis require inclusion Her2neu positive tumor . Previous history ipsilateral breast surgery impair cosmetic outcome , assess treat surgeon radiationoncologist . Collagen synthesis disease . Signs extensive DCIS component histological biopsy mammogram . Invasive lobular carcinoma . MRI absolute contraindication define Radiology Department . Nodal involvement cytological histological confirmation . Treatment neoadjuvant systemic therapy .</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>